Lensai Ophthalmic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
- Revenue Growth -22.01%
- Profit Growth 147.11%
- Ebitda 88.80%
- Net Worth 35.43%
- Total Assets -5.20%
About Lensai Ophthalmic
Lensai Ophthalmic Private Limited (LOPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 May 2010 and has a history of 14 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.00 M.
Divya Vyas, Ruchir Vyas, Sunita Vyas, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51394GJ2010PTC060884
-
Company No.
060884
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 May 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Lensai Ophthalmic?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ruchir Vyas
|
Director | 01-Apr-2022 | Current |
|
Divya Vyas
|
Director | 01-Apr-2022 | Current |
|
Sunita Vyas
|
Director | 05-Mar-2013 | Current |
|
Kashish Vyas
|
Director | 10-Jun-2019 | Current |
Financial Performance of Lensai Ophthalmic.
Lensai Ophthalmic Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 22.01% decrease. The company also saw a substantial improvement in profitability, with a 147.11% increase in profit. The company's net worth Soared by an impressive increase of 35.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lensai Ophthalmic?
In 2022, Lensai Ophthalmic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Qualtech Healthcare LlpSunita Vyas and Kashish Vyas are mutual person
-
Imag Medical Llp
Sunita Vyas and Kashish Vyas are mutual person
-
Kdans Surgical Pvt Ltd
Sunita Vyas is a mutual person
Charges (Loans)
₹7.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Apr 2013 | Indian Overseas Bank | ₹7.00 M | Open |
How Many Employees Work at Lensai Ophthalmic?
Unlock and access historical data on people associated with Lensai Ophthalmic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lensai Ophthalmic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lensai Ophthalmic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
